102 related articles for article (PubMed ID: 17998108)
1. A comparative study of 188Re(V)-meso-DMSA and 188Re(V)-rac-DMSA: preparation and in vivo evaluation in nude mice xenografted with a neuroendocrine tumor.
Park JY; Lee TS; Choi TH; Cheon GJ; Choi CW; Awh OD
Nucl Med Biol; 2007 Nov; 34(8):1029-36. PubMed ID: 17998108
[TBL] [Abstract][Full Text] [Related]
2. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies.
Blower PJ; Lam AS; O'Doherty MJ; Kettle AG; Coakley AJ; Knapp FF
Eur J Nucl Med; 1998 Jun; 25(6):613-21. PubMed ID: 9618576
[TBL] [Abstract][Full Text] [Related]
3. 188Re(V)-DMSA revisited: preparation and biodistribution of a potential radiotherapeutic agent with low kidney uptake.
Dadachova E; Chapman J
Nucl Med Commun; 1998 Feb; 19(2):173-81. PubMed ID: 9548202
[TBL] [Abstract][Full Text] [Related]
4. Comparison of chromatographic methods for quality control of DMSA complexes with 99mTc and 188Re at (III) and (V) oxidation states.
Garnuszek P; Pawlak D; Maurin M; Jankovic D; Karczmarczyk U; Mikołajczak R
Nucl Med Rev Cent East Eur; 2012 Aug; 15(2):95-100. PubMed ID: 22936501
[TBL] [Abstract][Full Text] [Related]
5. Uptake of the 188Re(V)-DMSA complex by cervical carcinoma cells in nude mice: pharmacokinetics and dosimetry.
García-Salinas L; Ferro-Flores G; Arteaga-Murphy C; Pedraza-López M; Hernández-Gutiérrez S; Azorin-Nieto J
Appl Radiat Isot; 2001 Mar; 54(3):413-8. PubMed ID: 11214875
[TBL] [Abstract][Full Text] [Related]
6. Preparation of [186Re]Re-DMSA and its bio-distribution studies.
Kothari K; Pillai MR; Unni PR; Shimpi HH; Noronha OP; Samuel AM
Appl Radiat Isot; 1999 Jul; 51(1):43-9. PubMed ID: 10376320
[TBL] [Abstract][Full Text] [Related]
7. 99Tcm-diastereomeric dimercaptosuccinic acid complexes: comparison of their biodistribution.
Awh OD; Kim JR; Shim SC
Nucl Med Commun; 1989 Jun; 10(6):449-54. PubMed ID: 2549480
[TBL] [Abstract][Full Text] [Related]
8. 99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.
Blower PJ; Kettle AG; O'Doherty MJ; Coakley AJ; Knapp FF
Eur J Nucl Med; 2000 Sep; 27(9):1405-9. PubMed ID: 11007525
[TBL] [Abstract][Full Text] [Related]
9. Novel tumortropic ester derivatives of 99mTc(V) mesodimercapto succinic acid with low affinity for bone tissue.
Seifert S; Syhre R; Spies H; Johannsen B
Nucl Med Commun; 2003 Nov; 24(11):1175-83. PubMed ID: 14569172
[TBL] [Abstract][Full Text] [Related]
10. Comparison of rac- and meso-2,3-dimercaptosuccinic acids for chelation of mercury and cadmium using chemical speciation models.
Fang X; Hua F; Fernando Q
Chem Res Toxicol; 1996; 9(1):284-90. PubMed ID: 8924605
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vivo lead mobilization of meso- and rac-2,3-dimercaptosuccinic acids in albino Wistar rats.
Jones MM; Singh PK; Kostial K; Blanusa M; Piasek M; Restek-Samarozija N
Pharmacol Toxicol; 1997 Apr; 80(4):182-6. PubMed ID: 9140137
[TBL] [Abstract][Full Text] [Related]
12. Preparation and in vivo evaluation of 90Y-meso-dimercaptosuccinic acid (90Y-DMSA) for possible therapeutic use: comparison with 99mTc-DMSA.
Djokić D; Janković D; Nikolić N
Cancer Biother Radiopharm; 2009 Feb; 24(1):129-36. PubMed ID: 19243255
[TBL] [Abstract][Full Text] [Related]
13. Rhenium-188 labeled recombinant human plasminogen kringle5 (rhk5) and preliminary biodistribution. Evaluation in mice bearing A549 tumours.
Guo R; Ma Y; Zhang R; Liang S; Shen H; Xu H; Li B
Nuklearmedizin; 2011; 50(6):234-9. PubMed ID: 21808809
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure, and properties of rac-2,3-dimercaptosuccinic acid, a potentially useful chelating agent for toxic metals.
Fang X; Fernando Q
Chem Res Toxicol; 1994; 7(2):148-56. PubMed ID: 8199302
[TBL] [Abstract][Full Text] [Related]
15. Preparation and biological evaluation of 188Re-ethylenediamine-N,N,N',N'-tetrakis(methylene phosphonic acid) as a potential agent for bone pain palliation.
Oh SJ; Won KS; Moon DH; Cheon JH; Ha HJ; Jeong JM; Lee HK
Nucl Med Commun; 2002 Jan; 23(1):75-81. PubMed ID: 11748441
[TBL] [Abstract][Full Text] [Related]
16. Studies on the preparation and isomeric composition of 186Re- and 188Re-pentavalent rhenium dimercaptosuccinic acid complex.
Singh J; Reghebi K; Lazarus CR; Clarke SE; Callahan AP; Knapp FF; Blower PJ
Nucl Med Commun; 1993 Mar; 14(3):197-203. PubMed ID: 8384352
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of meso- and rac-2,3-dimercaptosuccinic acids and their zinc complexes in aqueous solution.
Fang X; Fernando Q
Chem Res Toxicol; 1994; 7(6):770-8. PubMed ID: 7696531
[TBL] [Abstract][Full Text] [Related]
18. Mobilisation of cadmium by meso- and racemic-2,3-dimercaptosuccinic acid (DMSA) in rats.
Blanusa M; Kostial K; Restek-Samarzija N; Piasek M; Jones MM; Singh PK
Pharmacol Toxicol; 2000 Oct; 87(4):179-81. PubMed ID: 11097272
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
[TBL] [Abstract][Full Text] [Related]
20. An alternative approach to the preparation of (188)Re radiopharmaceuticals from generator-produced [(188)ReO(4)](-): efficient synthesis of (188)Re(V)-meso-2,3-dimercaptosuccinic acid.
Bolzati C; Boschi A; Uccelli L; Duatti A; Franceschini R; Piffanelli A
Nucl Med Biol; 2000 Apr; 27(3):309-14. PubMed ID: 10832088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
